Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-02

Clinical Trial Update: A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy

View source ↗

Summary

This clinical trial update reports results for avelumab in adults with advanced urothelial cancer after chemotherapy; the study has completed and results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avelumab (avelumab)

Snippet

Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Conditions: Urothelial Cancer | Status: COMPLETED | Results posted: 2025-12-02